VYANT BIO, INC. Resumen de negocios
Número de empleados: 4
Ventas por actividad
| USD en millones | 2021 | Peso | 2022 | Peso | Delta |
|---|---|---|---|---|---|
Central Nervous System Drug
85,1
%
| 0 | 42,1 % | 1 | 85,1 % | +17,39 % |
Services
14,9
%
| 1 | 57,9 % | 0 | 14,9 % | -85,11 % |
Ventas por región
| USD en millones | 2021 | Peso | 2022 | Peso | Delta |
|---|---|---|---|---|---|
United States
53,0
%
| 1 | 61,0 % | 0 | 53,0 % | -49,59 % |
International
47,0
%
| 0 | 39,0 % | 0 | 47,0 % | -30,09 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Andrew LaFrence
CEO | Chief Executive Officer | 61 | 01/08/19 |
John Roberts
BRD | Director/Board Member | 65 | 01/04/18 |
Yung Ping Yeh
BRD | Director/Board Member | 48 | 01/03/21 |
| - | - |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Geoffrey Harris
BRD | Director/Board Member | 61 | 01/01/14 |
Joanna Horobin
BRD | Director/Board Member | 69 | 01/01/21 |
R. Fletcher
CHM | Chairman | 78 | 30/03/21 |
| - | - | ||
Howard McLeod
BRD | Director/Board Member | 57 | 01/01/14 |
Yung Ping Yeh
BRD | Director/Board Member | 48 | 01/03/21 |
Paul Hansen
BRD | Director/Board Member | 61 | 01/01/21 |
John Roberts
BRD | Director/Board Member | 65 | 01/04/18 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 6 328 752 | 5 140 411 ( 81,22 %) | 0 | 81,22 % |
Información de la empresa
Vyant Bio, Inc.
2 Executive Campus 2370 State Route 70 West
08002, Cherry Hill
+
http://www.vyantbio.com
Ventas por actividad
Ventas por región
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +107,83 % | 6426,6 M | |
| +98,02 % | 1249,71 M | |
| +2,67 % | 987 M | |
| +20,03 % | 785 M | |
| +2,01 % | 666 M | |
| -2,15 % | 593 M | |
| -.--% | 600 M | |
| +10,28 % | 536 M | |
| -.--% | 500 M |
